Eiko Lifesciences Ltd - 540204 - First And Final Call On Partly Paid Up Equity Shares
Considered and approved the making of first and final call of Rs. 31.50/- on 55,44,178 Partly Paid Up Equity Shares14-12-2023
14-12-2023
Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Outcome Of The Meeting Of The Right Issue Committee Of Board Of Directors Held Today On 14Th December 2023
This is to inform you that the Meeting of the Right Issue Committee of the Board of Directors of the Company held today i.e., Thursday 14th December 2023 has inter alia considered and approved the making of First and Final Call of Rs. 31.50/- (Rupees Thirty-One and Fifty Paise Only) on 55,44,178 Partly Paid-up Equity Shares having Face Value of Re. 10/- each which were issued and allotted on 02nd August 2023 on Right Basis pursuant to the Letter of Offer ("LOF") dated 07th July 2023.14-12-2023
Eiko Lifesciences Ltd - 540204 - Board Meeting Intimation for Board Meeting Intimation For The Meeting Of The Rights Issue Committee Of Board Of Directors Of Eiko Lifesciences Limited (''Company'') Is Scheduled To Be Held On Thursday, December 12, 2023
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/12/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we hereby inform you that a meeting of Rights Issue Committee of Board of Directors the Company is scheduled to be held on Thursday, 14th December, 2023 to consider inter-alia and to approve the following matters; 1) Matter relating to payment of First and final call money on 55,44,178 partly paid-up equity shares of face value of Re. 10/- each which were issued and allotted on August 02, 2023 on right basis, pursuant to the Letter of Offer dated July 07, 2023. 2) Any other matter with the permission of the Chair. Thanking You,11-12-2023
Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby enclose the copy of newspaper publication giving information of Financial results as specified in Regulation 33 of Listing regulations. The results are published in Financial express (English Newspaper) and Mumbai Lakshadweep (Marathi Newspaper) on 09th November,202309-11-2023
Eiko Lifesciences Ltd - 540204 - Nil Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Nil Statement of deviation(s) and Variation (s) under Regulation 32 of SEBI (Listing Obligations and Disclosure Regulations,201508-11-2023
Eiko Lifesciences Ltd - 540204 - Appointment of Company Secretary and Compliance Officer
Appointment of Mr. Chintan Doshi having membership no ACS: 36190 as Company Secretary and Compliance Officer of the Company08-11-2023
Eiko Lifesciences Ltd - 540204 - Financial Results For Quarter And Half Year Ended 30Th September, 2023
Financial Results for the Quarter and Half year ended 30th September,202308-11-2023
Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Outcome Of The Board Meeting
Pursuant to Regulation 30 and 33 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations'), we would like to inform you that the Board of Directors in their meeting held today i.e., 08th November,2023 inter-alia, approved the following matters: 1. Considered and approved the Un-audited Financial Results of the Company for the quarter and half year ended on 30th September, 2023 along with the Limited review Report given by Statutory Auditor of the Company (Annexure - A). 2. Appointment of Mr. Chintan B. Doshi (ICSI Membership No. ACS 36190) as a 'Company Secretary and Compliance Officer' pursuant to section 203 of the Companies Act, 2013 and Regulation 6(1) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 with immediate effect.08-11-2023
Eiko Lifesciences Ltd - 540204 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure ) Regulations, 2015.
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve 1. The unaudited financial results of the Company for the quarter and half year ended 30th September, 2023. 2. Any other matter with the permission of the chair.30-10-2023
Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for 2B Black Bio LLP27-10-2023